Biogen Idec Inc

More

• Final Glance: Biotechnology companies Monday, 20 May 2013 | 6:04 PM ET

  Amgen Inc. fell $3.45 or 3.3 percent, to $102.18. Biogen Idec fell $1.67 or. 7 percent, to $225.18. Celgene Corp. fell $1.79 or 1.4 percent, to $123.12.

• UPDATE 3-Royalty raises Elan bid, issues ultimatum to shareholders Monday, 20 May 2013 | 3:27 PM ET

  *Bid raised to $12.50/ share from $11.25. DUBLIN/ NEW YORK, May 20- Royalty Pharma raised its hostile bid for Elan to $12.50 per share and threatened to withdraw the bid if Elan shareholders approve a series of defensive transactions announced by the Irish drug firm. Royalty previously offered $11.25 a share.

• UPDATE 2-Royalty ups Elan bid and issues shareholder ultimatum Monday, 20 May 2013 | 1:43 PM ET

  DUBLIN, May 20- Royalty Pharma raised its hostile bid for Elan to $12.50 per share and heaped pressure on shareholders, saying it will withdraw the bid if they approve a series of defensive transactions announced by the Irish drug firm.

• Midday Glance: Biotechnology companies Monday, 20 May 2013 | 1:16 PM ET

  Amgen Inc. fell $3.37 or 3.2 percent, to $102.26. Biogen Idec fell$. 36 or. 2 percent, to $226.49. Celgene Corp. fell $1.18 or. 9 percent, to $123.73.

• Early Glance: Biotechnology companies Monday, 20 May 2013 | 10:31 AM ET

  Amgen Inc. fell $1.36 or 1.3 percent, to $104.28. Biogen Idec rose $5.05 or 2.2 percent, to $231.90. Celgene Corp. fell$. 33 or. 3 percent, to $124.58.

• UPDATE 1-Elan strikes more deals to repel Royalty bid Monday, 20 May 2013 | 5:17 AM ET

  DUBLIN, May 20- Elan announced its second major drug deal inside a week on Monday and said it would buy back more shares as it continues to bat against a $5.7 billion takeover bid from U.S. investor Royalty Pharma.

• Final Glance: Biotechnology companies Friday, 17 May 2013 | 6:03 PM ET

  Amgen Inc. rose$. 66 or. 6 percent, to $105.63. Biogen Idec fell $1.14 or. 5 percent, to $226.85. Celgene Corp. rose $1.43 or 1.2 percent, to $124.91.

• Midday Glance: Biotechnology companies Friday, 17 May 2013 | 1:32 PM ET

  Amgen Inc. fell$. 13 or. 1 percent, to $104.84. Biogen Idec fell $3.07 or 1.3 percent, to $224.92. Celgene Corp. fell$. 34 or. 3 percent, to $123.14.

• Early Glance: Biotechnology companies Friday, 17 May 2013 | 10:25 AM ET

  Amgen Inc. rose$. 64 or. 6 percent, to $105.61. Biogen Idec fell $1.82 or. 8 percent, to $226.17. Celgene Corp. rose$. 43 or. 3 percent, to $123.91.

• Final Glance: Biotechnology companies Thursday, 16 May 2013 | 6:03 PM ET

  Amgen Inc. fell $2.45 or 2.3 percent, to $104.97. Biogen Idec rose$. 86 or. 4 percent, to $227.99. Celgene Corp. fell $6.15 or 4.7 percent, to $123.48.

• Midday Glance: Biotechnology companies Thursday, 16 May 2013 | 1:29 PM ET

  Amgen Inc. fell $2.16 or 2.0 percent, to $105.26. Biogen Idec fell $2.26 or 1.0 percent, to $224.87. Celgene Corp. fell $6.14 or 4.7 percent, to $123.49.

• Early Glance: Biotechnology companies Thursday, 16 May 2013 | 10:34 AM ET

  Amgen Inc. fell $2.58 or 2.4 percent, to $104.84. Biogen Idec fell $3.05 or 1.3 percent, to $224.08. Celgene Corp. fell $3.47 or 2.7 percent, to $126.16.

• Final Glance: Biotechnology companies Wednesday, 15 May 2013 | 6:02 PM ET

  Amgen Inc. fell$. 52 or. 5 percent, to $107.42. Biogen Idec fell $2.71 or 1.2 percent, to $227.13. Celgene Corp. fell$. 54 or. 4 percent, to $129.63.

• Midday Glance: Biotechnology companies Wednesday, 15 May 2013 | 1:26 PM ET

  Amgen Inc. rose$. 05 or percent, to $107.99. Biogen Idec fell$. 18 or. 1 percent, to $229.66. Celgene Corp. fell$. 18 or. 1 percent, to $129.99.

• Early Glance: Biotechnology companies Wednesday, 15 May 2013 | 10:23 AM ET

  Amgen Inc. fell$. 18 or. 2 percent, to $107.76. Biogen Idec fell $3.29 or 1.4 percent, to $226.55. Celgene Corp. fell$. 96 or. 7 percent, to $129.21.

• Final Glance: Biotechnology companies Tuesday, 14 May 2013 | 6:02 PM ET

  Amgen Inc. rose $1.52 or 1.4 percent, to $107.94. Biogen Idec rose $7.10 or 3.2 percent, to $229.84. Celgene Corp. rose$. 51 or. 4 percent, to $130.17.

• Jim Cramer’s 5 Investing Sweet Spots Tuesday, 14 May 2013 | 6:00 PM ET

  

  Following are 5 themes and related stock ideas that Jim Cramer likes right here and right now.

• Midday Glance: Biotechnology companies Tuesday, 14 May 2013 | 2:10 PM ET

  Amgen Inc. rose $1.69 or 1.6 percent, to $108.11. Biogen Idec rose $4.92 or 2.2 percent, to $227.66. Celgene Corp. rose$. 70 or. 5 percent, to $130.36.

• Early Glance: Biotechnology companies Tuesday, 14 May 2013 | 10:36 AM ET

  Amgen Inc. rose $2.23 or 2.1 percent, to $108.65. Biogen Idec rose $4.72 or 2.1 percent, to $227.46. Celgene Corp. rose $1.72 or 1.3 percent, to $131.38.

• Final Glance: Biotechnology companies Monday, 13 May 2013 | 6:02 PM ET

  Amgen Inc. rose$. 17 or. 2 percent, to $106.89. Biogen Idec rose $9.52 or 4.5 percent, to $222.74. Celgene Corp. rose $2.20 or 1.7 percent, to $129.66.